Compare · ORKA vs TKNO
ORKA vs TKNO
Side-by-side comparison of Oruka Therapeutics Inc. (ORKA) and Alpha Teknova Inc. (TKNO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ORKA and TKNO operate in Biotechnology: In Vitro & In Vivo Diagnostic Substances (Health Care), so they compete in similar markets.
- ORKA is the larger of the two at $3.86B, about 15.5x TKNO ($249.3M).
- Over the past year, ORKA is up 409.4% and TKNO is down 21.9% - ORKA leads by 431.2 points.
- ORKA has been more active in the news (11 items in the past 4 weeks vs 4 for TKNO).
- ORKA has more recent analyst coverage (11 ratings vs 7 for TKNO).
PerformanceORKA+409.39%TKNO-21.86%
2025-06-09+0.00%2026-06-08
- Company
- Oruka Therapeutics Inc.
- Alpha Teknova Inc.
- Price
- $64.03+6.51%
- $4.63+1.87%
- Market cap
- $3.86B
- $249.3M
- 1M return
- +0.02%
- +15.61%
- 1Y return
- +409.39%
- -21.86%
- Industry
- Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- News (4w)
- 11
- 4
- Recent ratings
- 11
- 7
Latest ORKA
- Oruka Therapeutics Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- SEC Form 4 filed by Director Dambkowski Carl
- SEC Form 4 filed by Director Kulkarni Samarth
- SEC Form 4 filed by Director Martin Christopher Nathan
- SEC Form 4 filed by Director Ball Kristine M
- SEC Form 4 filed by Director Fairmount Funds Management Llc
- Oruka Therapeutics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Phase 2 Data could Transform these Biotechs from Clinical Promise to Market Validation
- Oruka Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference
- Director Dambkowski Carl exercised 62,260 shares at a strike of $7.95 and sold $6,191,366 worth of shares (105,000 units at $58.97) as part of a pre-agreed trading plan, decreasing direct ownership by 37% to 73,743 units (SEC Form 4)
Latest TKNO
- SEC Form 4 filed by Director Vos Alexander
- SEC Form 4 filed by Director Robertson Brett
- SEC Form 4 filed by Director Demski Martha J
- Alpha Teknova Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- SEC Form 10-Q filed by Alpha Teknova Inc.
- Alpha Teknova Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits, Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
- Teknova Reports First Quarter 2026 Financial Results
- Teknova to Report First Quarter 2026 Financial Results on May 6, 2026
- SEC Form DEFA14A filed by Alpha Teknova Inc.
- SEC Form DEF 14A filed by Alpha Teknova Inc.